Immunotherapy in Prostate Cancer

被引：1
|
作者：
Bolat, Deniz [1 ,3 ]
Haydaroyu, Ayfer [2 ,3 ]
机构：
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Clin Urol, Izmir, Turkey
[2] Ege Univ, Dept Radiat Oncol, Fac Med, Izmir, Turkey
[3] Ege Univ, Inst Hlth Sci, Dept Basic Oncol, Izmir, Turkey
来源：
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2019年 / 18卷 / 02期
关键词：
Prostate cancer; immunotherapy; vaccine; checkpoint blockers; survival; PHASE-III TRIAL; SIPULEUCEL-T; ANDROGEN DEPRIVATION; CTLA-4; BLOCKADE; DOSE-ESCALATION; PD-1; DOUBLE-BLIND; SURVIVAL; VACCINE; CHEMOTHERAPY;
D O I：
10.4274/uob.galenos.2018.1142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.
引用
收藏
页码：67 / 72
页数：6
相关论文
共 50 条
  • [1] Immunotherapy of prostate cancer
    Doehn, Christian
    EUROPEAN UROLOGY, 2008, 53 (04) : 681 - 683
  • [2] Immunotherapy for prostate cancer
    Karnes, RJ
    Whelan, CM
    Kwon, ED
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (07) : 807 - 817
  • [3] The immunotherapy of prostate cancer
    Dalgleish, AG
    Perry, MJA
    Eaton, JD
    Hrouda, D
    Todryk, SM
    Kirby, RS
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 303 - 307
  • [4] Immunotherapy for prostate cancer
    Fong, L
    Small, EJ
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 649 - 658
  • [5] Prostate Cancer Immunotherapy
    Karan, Dev
    Van Veldhuizen, Peter
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (04) : 237 - 237
  • [6] IMMUNOTHERAPY FOR PROSTATE CANCER?
    Drake, C.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Immunotherapy for Prostate Cancer
    Djavan, Bob
    CANADIAN JOURNAL OF UROLOGY, 2011, 18 (04) : 5763 - 5763
  • [8] Immunotherapy and prostate cancer
    Kaminski, JM
    Summers, JB
    Ward, MB
    Huber, MR
    Minev, B
    CANCER TREATMENT REVIEWS, 2003, 29 (03) : 199 - 209
  • [9] Immunotherapy for prostate cancer
    Fong L.
    Small E.J.
    Current Oncology Reports, 2007, 9 (3) : 226 - 233
  • [10] Immunotherapy of prostate cancer
    Freedland S.J.
    Pantuck A.J.
    Weider J.
    Zisman A.
    Belldegrun A.S.
    Current Urology Reports, 2001, 2 (3) : 242 - 247
12345